0001225208-11-011358.txt : 20110406 0001225208-11-011358.hdr.sgml : 20110406 20110406114500 ACCESSION NUMBER: 0001225208-11-011358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110404 FILED AS OF DATE: 20110406 DATE AS OF CHANGE: 20110406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH ALAN E CENTRAL INDEX KEY: 0001021037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 11742387 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml X0303 4 2011-04-04 0000732485 GENZYME CORP GENZ 0001021037 SMITH ALAN E 500 KENDALL STREET CAMBRIDGE MA 02142 1 Sr VP,Chief Scientific Officer Genzyme common stock (GENZ) 2011-04-04 4 M 0 5120.0000 0 A 42741.0000 D Genzyme common stock (GENZ) 2011-04-04 4 M 0 2695.0000 0 A 45436.0000 D Genzyme common stock (GENZ) 2011-04-04 4 D 0 7815.0000 74.0000 D 37621.0000 D Genzyme common stock (GENZ) 2011-04-04 4 U 0 37621.0000 74.0000 D 0.0000 D Genzyme common stock (GENZ) 2011-04-04 4 U 0 221.0000 74.0000 D 0.0000 I By 401(k) Restricted Stock Units 2011-04-04 4 M 0 5120.0000 0.0000 D 2010-05-21 Genzyme common stock (GENZ) 5120.0000 0.0000 D Restricted Stock Units 2011-04-04 4 M 0 2695.0000 0.0000 D 2009-05-22 Genzyme common stock (GENZ) 2695.0000 2694.0000 D Stock Option (right to buy) 51.5200 2011-04-04 4 D 0 23038.0000 51.5200 D 2020-06-16 Genzyme common stock (GENZ) 23038.0000 0.0000 D Stock Option (right to buy) 58.6600 2011-04-04 4 D 0 23038.0000 58.6600 D 2009-05-21 2019-05-21 Genzyme common stock (GENZ) 23038.0000 0.0000 D Stock Option (right to buy) 68.4800 2011-04-04 4 D 0 24250.0000 68.4800 D 2008-05-22 2018-05-22 Genzyme common stock (GENZ) 24250.0000 0.0000 D Stock Option (right to buy) 62.1600 2011-04-04 4 D 0 24250.0000 62.1600 D 2007-05-24 2017-05-24 Genzyme common stock (GENZ) 24250.0000 0.0000 D Stock Option (right to buy) 58.5000 2011-04-04 4 D 0 48500.0000 58.5000 D 2006-05-25 2016-05-25 Genzyme common stock (GENZ) 48500.0000 0.0000 D Stock Option (right to buy) 62.9800 2011-04-04 4 D 0 48500.0000 62.9800 D 2005-05-26 2015-05-26 Genzyme common stock (GENZ) 48500.0000 0.0000 D Stock Option (right to buy) 43.9000 2011-04-04 4 D 0 57000.0000 43.9000 D 2004-05-27 2014-05-27 Genzyme common stock (GENZ) 57000.0000 0.0000 D Stock Option (right to buy) 46.2400 2011-04-04 4 D 0 45000.0000 46.2400 D 2003-05-29 2013-05-29 Genzyme common stock (GENZ) 45000.0000 0.0000 D Stock Option (right to buy) 41.5000 2011-04-04 4 D 0 830.0000 41.5000 D 2002-05-30 2012-05-30 Genzyme common stock (GENZ) 830.0000 0.0000 D Stock Option (right to buy) 32.5200 2011-04-04 4 D 0 66300.0000 32.5200 D 2002-05-30 2012-05-30 Genzyme common stock (GENZ) 66300.0000 0.0000 D Stock Option (right to buy) 32.5200 2011-04-04 4 D 0 9225.0000 32.5200 D 2005-05-30 2012-05-30 Genzyme common stock (GENZ) 9225.0000 0.0000 D Stock Option (right to buy) 53.4700 2011-04-04 4 D 0 44000.0000 53.4700 D 2001-05-31 2011-05-31 Genzyme common stock (GENZ) 44000.0000 0.0000 D The vested restricted stock units were scheduled to be released on 5/22/2011 and 5/21/2012. This option, which provided for vesting 20% at grant and 20% annually over four years, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option. Susan P. Cogswell, Attorney-in-Fact 2011-04-06